In vivo assessment of β-hydroxybutyrate metabolism in mouse brain using deuterium (2H) MRS
Narayan Datt Soni, Anshuman Swain, Paul Jacobs, Halvor Juul, Ryan Armbruster, Ravi Prakash Reddy Nanga, Kavindra Nath, Corinde Wiers, John Detre, Ravinder Reddy
Abstract
Purpose
To monitor the metabolic turnover of β-hydroxybutyrate (BHB) oxidation using 2H-MRS in conjunction with intravenous administration of 2H labeled BHB.
Methods
Nine-month-old mice were infused with [3,4,4,4]-2H4-BHB (d4-BHB; 3.11 g/kg) through the tail vein using a bolus variable infusion rate for a period of 90 min. The labeling of downstream cerebral metabolites from the oxidative metabolism of d4-BHB was monitored using 2H-MRS spectra acquired with a home-built 2H surface coil on a 9.4T preclinical MR scanner with a temporal resolution of 6.25 min. An exponential model was fit to the BHB and glutamate/glutamine (Glx) turnover curves to determine rate constants of metabolite turnover and to aid in the visualization of metabolite time courses.
Results
Deuterium label was incorporated into Glx from BHB metabolism through the tricarboxylic acid (TCA) cycle, with an increase in the level of [4,4]-2H2-Glx (d2-Glx) over time and reaching a quasi-steady state concentration of ∼0.6 ± 0.1 mM following 30 min of infusion. Complete oxidative metabolic breakdown of d4-BHB also resulted in the formation of semi-heavy water (HDO), with a four-fold (10.1 to ∼42.1 ± 7.3 mM) linear (R2 = 0.998) increase in its concentration by the end of infusion. The rate constant of Glx turnover from d4-BHB metabolism was determined to be 0.034 ± 0.004 min−1.
Conclusion
2H-MRS can be used to monitor the cerebral metabolism of BHB with its deuterated form by measuring the downstream labeling of Glx. The integration of 2H-MRS with deuterated BHB substrate provides an alternative and clinically promising MRS tool to detect neurometabolic fluxes in healthy and disease conditions.